Skip to main content
Loading

Selecting and optimizing oligonucleotide delivery approaches during discovery, aligning chemistry, format, and screening models to enable downstream development

03 Sept 2026
Oligonucleotide Delivery
Industry Expert
Zoya Gluzman-Poltorak, CEO & Co-Founder - Forta Bio